The AI Adoption Arc: Pharma’s First Steps with AI
Guest: Nathan Trueblood, Chief Product Officer, Enkrypt AI
Host: Jane Urban, Chief Data & Analytics Officer, Improzo
Date : November 13, 2025
Time : 17 min
About the Episode
Welcome to The Improzone! In this four-part mini-series, we explore the journey of AI adoption in Life Sciences — from cautious beginnings to enterprise-wide transformation.
In Part 1, Pharma’s First Steps with AI, Improzo’s Chief Data & Analytics Officer Jane Urban is joined by Nathan Trueblood, Chief Product Officer, Enkrypt AI , to discuss how organizations can move from early curiosity to practical, low-risk engagement with AI. The discussion focuses on shifting from hype to purpose, understanding how AI can serve as a true partner in decision-making, and overcoming the cultural and operational barriers that often stand in the way of progress.
This episode is about building confidence and defining what responsible, practical AI adoption looks like in the real world of pharma.
Highlights from the Episode:
- Move beyond the hype and focus on solving meaningful business and patient-impact challenges.
- Treat AI as a co-pilot that enhances decisions with intelligence, trust, and context.
- Recognize that the biggest challenge to AI adoption is human, not technical.
- Begin with visibility and guided experimentation to enable faster, safer adoption.
- Bridge structured and unstructured data to uncover the deeper “why” behind insights.
Tune In for the Next Episode
In Part 2 of 4 — From Experiment to Execution, we will explore how to scale initial AI wins into repeatable success stories, embedding compliance, integration, and governance into your AI strategy.
Listen to the full episode
Recommended content
Watch Now
About the Authors
Jane Urban
Chief Data & Analytics Officer
Nathan Trueblood
Chief Product Officer, Enkrypt AI